DSC
DGX icon

Duncker Streett & Co’s Quest Diagnostics DGX Stock Holding History

Duncker Streett & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-147
Closed -$16K – 531
2019
Q4 		$16K Buy
+147
New +$15.3K ﹤0.01% 439

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Duncker Streett & Co's DGX Position: Q1 2020 in Review

Duncker Streett & Co sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 147 shares — an estimated $16K sold.

Duncker Streett & Co first reported a position in DGX in Q4 2019 and held it in 1 quarter. The position peaked at $16K in Q4 2019. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

  • Duncker Streett & Co reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
  • Duncker Streett & Co sold 147 Quest Diagnostics shares in Q1 2020, an estimated $16K.
  • Duncker Streett & Co first reported a position in Quest Diagnostics in Q4 2019 and held it in 1 quarter.
  • Duncker Streett & Co's Quest Diagnostics position peaked at $16K in Q4 2019.
  • 714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Duncker Streett & Co's 13F filing for Q1 2020, filed 27 Apr 2020.